insights_auto
Outlook: 25.0% bullish·0.0% bearish
Go to analysischevron_right
MYX:ASX
Mayne Pharma Group Ltd
A$6.04
arrow_downward
-0.33%(-0.020) 1D
Nov 20, 4:10:07 PM GMT+11 · AUD
search
All symbols
No data
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MYX...
Open
A$6.05
High
A$6.07
Low
A$6.03
Mkt. cap
494.62M
Avg. vol.
555.22K
Volume
2.37M
P/E ratio
15.48
52-wk high
A$6.10
52-wk low
A$2.04
EPS
A$0.39
Shares outstanding
81.89M
No. of employees
363
Open
A$6.05
High
A$6.07
Low
A$6.03
Mkt. cap
494.62M
Avg. vol.
555.22K
Volume
2.37M
P/E ratio
15.48
52-wk high
A$6.10
52-wk low
A$2.04
EPS
A$0.39
Shares outstanding
81.89M
No. of employees
363
News stories
From web sources and news partners
About Mayne Pharma Group Ltd
CEO-
Employees363
Founded2005
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websitemaynepharma.com
Previous reportsAll values in AUD
Loading Previous Earnings...
Income statement
Revenue
Net income
- Quarterly
- Annual
All values in AUD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
Revenue | 106.04M | 106.04M | 85.80M | 85.80M |
Cost of goods sold | 36.75M | 36.75M | 31.06M | 31.06M |
Cost of revenue | 36.75M | 36.75M | 31.06M | 31.06M |
Research and development expenses | 6.36M | 6.36M | 4.02M | 4.02M |
Total research and development expenses | - | - | - | - |
Selling, general, and admin expenses | 73.70M | 73.70M | 53.25M | 53.25M |
Operating expense | 80.05M | 80.05M | 57.27M | 57.27M |
Total operating expenses | 116.80M | 116.80M | 88.32M | 88.32M |
Operating income | -10.76M | -10.76M | -2.52M | -2.52M |
Other non operating income | -9.67M | -9.67M | -7.25M | -7.25M |
EBT including unusual items | 2.77M | 2.77M | 15.11M | 15.11M |
EBT excluding unusual items | -22.40M | -22.40M | -11.56M | -11.56M |
Income tax expense | 8.82M | 8.82M | -6.54M | -6.54M |
Effective tax rate | 318.56% | 318.56% | -43.28% | -43.28% |
Other operating expenses | - | - | - | - |
Net income | -7.47M | -7.47M | 19.71M | 19.71M |
Net profit margin | -7.04% | -7.04% | 22.97% | 22.97% |
Earnings per share | - | - | - | - |
Interest and investment income | 761.00K | 761.00K | 1.08M | 1.08M |
Interest expense | -1.31M | -1.31M | -1.35M | -1.35M |
Net interest expenses | -546.00K | -546.00K | -267.50K | -267.50K |
Depreciation and amortization charges | - | - | - | - |
EBITDA | 5.09M | 5.09M | 11.46M | 11.46M |
Gain or loss from assets sale | - | - | - | - |
Upcoming events